Summary A panel of human lung carcinoma lines representing the four main histological types (squamous, small-cell, large-cell and adeno-carcinoma), and derived from both primary and metastatic sites, has been established in xenograft and in tissue culture. The highest take rates were achieved when biopsy specimens were obtained from large tumour masses and cultured lines were most readily established after preliminary passages as xenografts. The established lines exhibited an overlapping spectrum of biochemical and morphological characteristics, and showed a tendency to change from one cell type to another, in keeping with the concept of a common endodermal cell of origin. Radiation resistance appeared to be related to the large-cell phenotype.
The World Health Organisation (1981) recognises four main histological types of lung cancer, with differing patterns of clinical and biological behaviour, and varying prognostic and therapeutic implications. The most important distinctions are between small-cell and non-small-cell carcinomas, the former possessing neuroendocrine properties and relative therapeutic sensitivity and the latter, features more typical of tissues of endodermal origin and with greater resistance to treatment. Since the first reported derivation of a small-cell carcinoma line in tissue culture (Oboshi et al., 1971) , a number of cell lines have been established, particularly from small-cell carcinoma, and these have been the subject of extensive investigation of the biological properties of the different tumour types. A variety of phenotypic properties have been studied, including the expression of intermediate filaments, neural enzymes and hormones, and growth characteristics and requirements. As yet it has not been possible to attribute any differences in therapeutic sensitivity directly to these biological properties but they may relate to the observed differences in clinical behaviour and therefore warrant further study.
The panel of lines described here was established in order to investigate the interrelationships of the different cell types, to determine growth requirements and therapeutic sensitivity, and to see whether any relationship to clinical sensitivity could be derived. A particular effort was made to obtain material from primary tumours, as the majority of lines previously studied have been derived from metastatic lesions (e.g. Carney et al., 1985) .
Materials and methods

Specimens
Tumour samples were obtained from patients undergoing diagnostic or therapeutic procedures, and transferred to the laboratory in cold tissue culture medium (Ham's F12) . Solid specimens obtained at thoracotomy or removal of subcutaneous metastases were chopped into small fragments and implanted subcutaneously into male athymic nude mice (BALB/c). Tumour fragments were also disaggregated into single-cell suspensions using an enzyme mixture consisting of pronase (Calbio-Behring) , DNase (Sigma) and collagenase (Boehringer-Mannheim), at 0.5, 0.2 and 0.2mg ml-in serum-free medium respectively, prior to placing in tissue culture.
Specimens of bone marrow, or pleural or pericardial. (Chen, 1977 Assay of L-dopa decarboxylase (DDC) DDC was assayed using a modification of the technique described by Beaven et al. (1978) , measuring the release of 14CO2 from 14C-labelled 3,4-dihydroxyphenylalanine (Amersham International) by the enzyme in cell sonicates. Essentially, non-enzymatic decarboxylation of the substrate was inhibited using 1 mM 2-mercaptoethanol (Sigma) and 0.1 mM versene (BDH), and the assay was conducted at pH 7.6 in 0.1 M Tris buffer. The enzyme levels were expressed as nanomols of 14CO2 released per hour per mg of soluble protein; protein was measured using the Bradford technique, (Bradford, 1976) , measuring change in optical density occurring with protein-dye binding.
Assay of neuron-specific enolase (NSE) Assay of this enzyme was performed using a modification of the method of Cooper et al. (1985) using a radioimmunoassay developed by Pharmacia, Sweden for the measurement of enzyme levels in serum. Soluble protein fractions from the tumour lines were prepared by sonication and ultracentrifugation at 4°C and 100,000g for 40 min, and aliquots of the supernatant were assayed for NSE and protein concentration. Standard and unknown aliquots were incubated with 12 5-labelled NSE and rabbit anti-NSE antiserum and the bound NSE was then precipitated with a sheep antirabbit IgG-sepharose complex, centrifuged at 1,500g for 10 min and the activity in the residual pellet counted. The unknown levels were determined from the standard calibration curve, and the NSE levels expressed as ng mg 1 soluble protein.
Assay of immunoreactive bombesin (IRB)
A double antibody radioimmunoassay technique (Immunonuclear Corporation) was used to determine the levels of immunoreactive bombesin in the tumour lines. The soluble protein fraction obtained from freeze-dried preparations of the tumour cell lines was resuspended in distilled water and aliquots were incubated with 1251-bombesin and rabbit antibombesin antiserum. The activity in the precipitated bound antibody complex was counted and the unknown bombesin concentrations derived from a standard calibration curve. The results were expressed as pmol bombesin mg-' of soluble protein.
Chromosome analysis Cell suspensions from tumours or cultured cell lines were incubated in fresh culture medium for 24h, and then with colcemid (Gibco Laboratories) at a final concentration of 0.05 to 0.1 ug ml -1 for 4 h. The cells were suspended in hypotonic potassium chloride solution (0.075 M) for 15 min and fixed using 3:1 methanol and glacial acetic acid, spread onto cold glass slides and stained with Giemsa for examination.
Radiation sensitivity
The sensitivities of the tumour lines to acute irradiation were determined using the soft agar clonogenic assay described by Courtenay and Mills (1978) . Single cell suspensions were irradiated at room temperature using a 60Co source at a dose rate of 1.5Gymin-1, and then cultured in soft agar until colony formation was observed. Survival after irradiation was calculated relative to control plating efficiency, and the responses were expressed in terms of the multitarget and linear quadratic models of survival (derived as described by Millar et al., 1978) , and the surviving fraction at 2 Gy, SF2 (Deacon et al., 1984) . Full details are described elsewhere (Duchesne et al., 1986) .
Results
Establishment of xenografts and cultured cell lines Forty-one tissue specimens were obtained from 38 patients; the types of specimen are detailed in Table I together with the positive take rates either in xenograft or in culture for the different histological types. Eleven of the 15 marrow specimens were negative for malignant cells on histological examination; one of these showed initial growth in culture of an undetermined cell type, which failed after 3 months. Seven fibre-optic bronchoscopy specimens were obtained, of which 2 did not contain malignant cells, and no successful culture or xenograft was established from the remaining 5 specimens. Tissue obtained at thoracotomy or from other large biopsies or malignant effusions resulted in a high take rate in xenografts (for solid specimens) or culture (effusions) for bronchogenic carcinoma but 2 carcinoid tumours, one oesphageal squamous carcinoma and one lymph node containing Hodgkin's disease failed to grow.
Of the 23 lung carcinoma specimens which contained cytologically detectable numbers of tumour cells, 13 were successfully established as tumour lines. Of these, ten (obtained from solid tumour specimens), were primarily established as xenograft lines, although no cultured cell line was derived directly from these tumours. Subsequently attention was focussed on deriving cell lines from xenografted tumours, and five such lines were successfully established in culture (HX144, HX147, HX148, HX149 and HX168 -see Table II ). Three primary cultures were established from effusions or bone marrow specimens (HC 12, HC38 and HC39) and were subsequently demonstrated to be tumorigenic in nude mice. The histological appearances of the xenograft tumours and tumours derived from inoculation of cell lines into nude mice were similar to those of the patient specimens from which they were derived, (e.g. Figure la , b -patient and xenograft tumours of HX147). Two sublines were derived from this panel of tumours through changes in the growth or morphological characteristics of an established xenograft or cell line. HX149, a classical small-cell carcinoma, grew slowly in the mouse host with a doubling time of 18.5 days, until a sudden acceleration of growth (with a tumour doubling time of 5.2 days) during the fourth xenograft passage was noted in one mouse, together with extensive subcutaneous spread. The histology of this tumour (designated HXI49M) was similar to that of the parent line, although the cells were slightly larger with more prominent nucleoli (Figure 2a, b) , and the line grew in tissue culture as an attached monolayer instead of the floating aggregates typical of the parent line (Figure 2c, d ). Ultrastructural examination of HX149 showed the presence of dense-core granules (Figure 3a ) but no evidence of features suggestive of epithelial differentiation, whereas HX149M contained desmosomes and microvilli in addition to occasional dense-core granules (Figure 3b ). Stored tissue from the second xenograft passage was reintroduced into nude mice but did not show the same acceleration of growth subsequently. The HX149M subline has been classed as a morphological variant small-cell carcinoma , supported by its biochemical profile (see Table III ); its human origin was confirmed by chromosomal analysis.
The second subline arose from the adenocarcinoma HX148 which was established in tissue culture from the fifth xenograft passage of the tumour. In early passages in tissue culture and xenograft ( Figure 1c ) small cells suggestive of adenocarcinoma in appearance, with a diploid modal chromosomal number, comprised the whole population of the line but between the 15th and 20th passage a population of large cells emerged ( Figure Id) and chromosomal analysis showed that 12% of the population now had an approximately tetraploid chromosome complement. This mixed adenocarcinoma/large-cell line was designated HXI48M, and the two cell types are currently being cloned. Some of the morphological and biochemical characteristics remain the same but others have altered between the cell types: for example, the expression of cytokeratins was not seen in all cells of the large-cell population, whereas consistent staining was observed throughout the smaller cells.
Chromosomal analysis
The human origin of all lines was confirmed by examination of metaphase spreads. The Neural enzymes and peptides Six lines established in tissue culture have been characterised in detail with respect to L-dopa decarboxylase, neuronspecific enolase, immunoreactive bombesin and creatine kinase BB isoenzyme (CK-BB) expression, and now form the basis of a panel of lines which is being further investigated with respect to therapeutic response. CK-BB was not measured directly but was examined using immunofluorescence. The classical small-cell carcinomas, the variant line HX149M, and the large-cell carcinoma HX147 all stained for the presence of this enzyme, and staining was particularly intense in HX149. In contrast, no staining was observed in either the small-or large-cell component of HX148M. Assay of the other three neural markers (Table  III) showed high levels of all these markers in the classical small-cell carcinomas, but also occasional production at low levels by the other lines examined.
Radiation sensitivity
The radiation survival parameters are presented in Table IV . No conclusive differences in Do (multitarget model) were found between the tumour types. Examination of the parameters a and SF2, thought to be more discriminating in intrinsic radiosensitivity (Fertil & Malaise, 1981) , showed that the classical small-cell carcinomas and the adenocarcinomas were significantly more radiosensitive than those lines containing a large-cell component (P<0.01 and P<0.05 respectively). Additionally the small-cell carcinoma cell line HC12 which had been heavily treated with both irradiation and drugs in the patient, was significantly less radiosensitive than those small-cell lines which had not been irradiated in situ (P<0.05). A decreased radiosensitivity was observed in the two sublines HX148M and HX149M which showed a change towards large-cell morphology, compared with the parent lines. RT: tumour treated with irradiation in the patient.
Discussion
The experience described here has allowed us to develop an efficient procedure with which to establish tumour lines, both as xenografts and in culture, from human lung cancer for further laboratory study. An observation of practical importance is that lines have been most readily established from patient specimens in which large numbers of malignant cells were identified on light microscopy. Our experience with bronchoscopy specimens has shown that they rarely yield sufficient material to allow establishment of a line, and our attempts from fibreoptic bronchoscopy specimens were uniformly unsuccessful. Also of practical benefit was the ease of establishing of cell lines in tissue culture after the tumour line has first been passaged through a murine host, as suggested previously by Gazdar et al. (1981a) . The established cell lines retained the characteristics of the xenografts from which they were derived, which in turn resembled the patient tumours as far as could be determined (for example, in histological appearance and immunohistochemicBl staining, cell size and chromosomal complement). In addition, the radiation sensitivities of cells whether from xenografts or cultured cell lines derived from the same tumour did not differ significantly (Duchesne, unpublished observations) , supporting the usefulness of this approach in establishing representative cell lines.
The characterisation of the lines with respect to expression of neural and epithelial markers confirms the current view that all types of lung carcinoma arise from an epithelial origin. Previous observations of the expression of neuroendocrine enzymes and peptides by small-cell carcinomas (e.g. Gazdar et al., 1981b; Moody et al., 1981; Sheppard et al., 1984 ) demonstrated a clear distinction from the nonsmall-cell tumours, and suggested that these tumours might be neuroectodermal in origin. Later reports (e.g. Carney et al., 1985) , supported by the present findings, have demonstrated the expression of such properties by some nonsmall-cell carinomas, although generally to a lesser extent. This is in keeping with the concept that lung cancer cells may express markers of more than one differentiation pathway, and emphasises the close relationships of the cell types.
The pattern of intermediate filament expression in the different histological types also reflects the capacity of lung carcinoma cells to express markers of differing cell lineages, although neoplasms generally retain the intermediate filament structure of their tissue of origin (Altmannsberger et al., 1981) . All the lines studied here expressed cytokeratins, in keeping with previous reports (e.g. Bernal et al., 1983; Blobel et al., 1984) . Staining for neurofilament was observed in all the small-cell carcinomas, both classical and variant, and adenocarcinomas, but not in the squamous or large-cell lines. The expression of neurofilaments in small-cell carcinomas is still debated (e.g. Bergh et al., 1984; Van Muijen et al., 1984) , but the present observations would be consistent with the explanation offered by Clark et al. (1985) , that neurofilament expression is facultative, and occurs only in terminally differentiated cells.
The interrelationships of the cell types are also revealed by No consistent differences in biological behaviour or tumour markers were found between tumours from primary or metastatic sites, although it is recognised that the number of lines is small, and that any such differences might therefore not be detected. Consistent differences in radiation sensitivity have been found, however, between the different histological types, with the lines with a large-cell component exhibiting intrinsic radioresistance, and the other histological types being relatively radiosensitive. There is a suggestion that those small-cell lines which had not been previously irradiated (e.g. HX168, HC38 and HC39) were more radiosensitive than those which had been heavily pretreated, such as HC12 which showed therapeutic resistance to both drugs and radiation in the patient. Interestingly HC12, which is morphologically a classical small-cell carcinoma, exhibits a biochemical profile and radiation sensitivity intermediate between that of the other classical lines and the large-cell lines. It is tempting to speculate that the spectrum of radiosensitivity observed relates directly to the degree of expression of the neuroendocrine phenotype, and that the resistance to radiation observed clinically in some tumours may result from the presence or emergence of a large-cell, non-endocrine component.
The results presented here confirm the overlap of neuroendocrine and endodermal features in the small-cell and nonsmall-cell tumours and are in keeping with the current concept that all the tumours arise from a common cell of origin. It is suggested that there is no rigid distinction between the different tumour types but rather that the cells may undergo phenotypic alterations from one type to another. Radiation resistance appears to be related to the large-cell phenotype, and a spectrum of response is seen which parallels the spectrum of neuroendocrine expression.
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